Rankings
▼
Calendar
NVCR (NovoCure Limited) Stock Financials & Earnings | Market Cap Arena
NVCR
NovoCure Limited
Mkt Cap
$1B
Healthcare
·
Medical - Instruments & Supplies
·
Jersey
·
NASDAQ
Revenue (TTM)
$655M
Net Income (TTM)
-$136M
EPS (TTM)
-$1.22
Free Cash Flow (TTM)
-$76M
Gross Margin
74.5%
Op. Margin
-23.5%
Net Margin
-20.8%
FCF Margin
-11.5%
P/S Ratio (TTM)
2.2x
P/E Ratio (TTM)
—
YoY Rev Growth
+8.3%
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$122M
$93M
-$60M
Q2 23
$126M
$92M
-$63M
Q3 23
$127M
$95M
-$58M
Q4 23
$134M
$101M
-$52M
Q1 24
$139M
$105M
-$42M
Q2 24
$150M
$116M
-$34M
Q3 24
$155M
$120M
-$32M
Q4 24
$161M
$128M
-$63M
Q1 25
$155M
$116M
-$38M
Q2 25
$159M
$117M
-$40M
Q3 25
$167M
$122M
-$36M
Q4 25
$174M
$132M
-$40M
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
2.8x
—
Q2 23
2.8x
—
Q3 23
2.9x
—
Q4 23
2.8x
—
Q1 24
2.7x
—
Q2 24
2.6x
—
Q3 24
2.5x
—
Q4 24
2.4x
—
Q1 25
2.3x
—
Q2 25
2.3x
—
Q3 25
2.2x
—
Q4 25
2.2x
—
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$17M
-$23M
Q2 23
-$23M
-$30M
Q3 23
-$19M
-$27M
Q4 23
-$15M
-$21M
Q1 24
-$32M
-$43M
Q2 24
-$2M
-$13M
Q3 24
$10M
-$307K
Q4 24
-$3M
-$12M
Q1 25
-$36M
-$46M
Q2 25
-$16M
-$21M
Q3 25
$21M
$15M
Q4 25
-$18M
-$23M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$6M
Q2 23
$7M
Q3 23
$7M
Q4 23
$7M
Q1 24
$12M
Q2 24
$11M
Q3 24
$11M
Q4 24
$9M
Q1 25
$11M
Q2 25
$5M
Q3 25
$6M
Q4 25
$5M
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
-11.2%
+31.9%
Q2 23
-10.5%
+16.5%
Q3 23
-2.8%
+19.3%
Q4 23
+4.2%
+8.2%
Q1 24
+13.4%
-1.3%
Q2 24
+19.3%
-2.5%
Q3 24
+21.8%
+0.9%
Q4 24
+20.5%
+21.1%
Q1 25
+11.9%
+7.1%
Q2 25
+5.6%
+7.8%
Q3 25
+7.8%
+8.6%
Q4 25
+8.1%
-4.4%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$39M
32.0%
Q2 23
$33M
26.0%
Q3 23
$0
0.0%
Q4 23
$17M
13.0%
Q1 24
$34M
24.6%
Q2 24
$32M
21.2%
Q3 24
$31M
20.2%
Q4 24
$63M
38.9%
Q1 25
$30M
19.1%
Q2 25
$26M
16.5%
Q3 25
$29M
17.5%
Q4 25
$0
0.0%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
Quarter
R&D
G&A
S&M
Q1 23
$60M
$42M
$51M
Q2 23
$55M
$41M
$58M
Q3 23
$54M
$42M
$58M
Q4 23
$54M
$39M
$59M
Q1 24
$52M
$40M
$55M
Q2 24
$55M
$38M
$57M
Q3 24
$52M
$40M
$60M
Q4 24
$51M
$72M
$67M
Q1 25
$54M
$45M
$56M
Q2 25
$56M
$44M
$57M
Q3 25
$54M
$46M
$59M
Q4 25
$61M
$43M
$69M
marketcaparena.com
Revenue by Geography
China
Germany
Japan
Others Countries
United States
Quarter
China
Germany
Japan
Others Countries
United States
Q1 23
$5M
$15M
$9M
$8M
$85M
Q2 23
$7M
$16M
$8M
$9M
$87M
Q3 23
$7M
$15M
$8M
$12M
$86M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$186M
$772M
$958M
Q2 23
$157M
$784M
$941M
Q3 23
$155M
$766M
$921M
Q4 23
$241M
$670M
$911M
Q1 24
$454M
$416M
$870M
Q2 24
$168M
$786M
$955M
Q3 24
$185M
$774M
$960M
Q4 24
$164M
$796M
$960M
Q1 25
$127M
$802M
$929M
Q2 25
$150M
$762M
$912M
Q3 25
$345M
$691M
$1.0B
Q4 25
$103M
$354M
$458M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
106M
+0.6%
Q2 23
106M
+0.6%
Q3 23
107M
+0.5%
Q4 23
107M
+0.2%
Q1 24
107M
+0.3%
Q2 24
108M
+0.4%
Q3 24
108M
+0.5%
Q4 24
108M
-0.4%
Q1 25
110M
+2.3%
Q2 25
112M
+1.2%
Q3 25
112M
+0.3%
Q4 25
111M
-0.4%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 14
—
—
FY 15
$104K
318
FY 16
$180K
460
FY 17
$358K
495
FY 18
$415K
598
FY 19
$449K
782
FY 20
$483K
1K
FY 21
$458K
1K
FY 22
$407K
1K
FY 23
$351K
1K
FY 24
$407K
1K
FY 25
$440K
1K
marketcaparena.com